Kukje Pharma Co., Ltd.
002720 | KO
Overview
Corporate Details
- ISIN(s):
- KR7002720001
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 야탑로 96-8, 성남시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2025-09-04 00:00 |
Regulatory Filings
생산중단
|
Korean | 9.3 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-08-13 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.6 KB | ||
| 2025-05-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.7 KB | ||
| 2025-05-20 00:00 |
Related Party Transaction
[기재정정]타인에대한채무보증결정
|
Korean | 18.6 KB | ||
| 2025-05-15 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 23.4 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 503.8 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 20.1 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 983.8 KB | ||
| 2025-03-06 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 983.2 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.7 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.0 KB |
Automate Your Workflow. Get a real-time feed of all Kukje Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Kukje Pharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kukje Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
United States of America
ALDX
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
United States of America
ALEC
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK
Denmark
ALK
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia
ALK
North Macedonia
ALK
Develops medicines for CNS disorders like schizophrenia, bipolar, and sleep disorders.
United States of America
ALKS
United States of America
ALKS
Develops personalized cancer drugs using a diagnostic platform to predict patient response.
United States of America
ALLR
United States of America
ALLR
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom
AGY
United Kingdom
AGY
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden
ATORX
Sweden
ATORX
Developing off-the-shelf CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
ALLO
United States of America
ALLO
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain
ALM
Spain
ALM